RXST
RXST
NASDAQ · Health Care

Rxsight Inc

$6.19
-0.15 (-2.37%)
Financial Highlights (FY 2026)
Revenue
137.97M
Net Income
-39,953,072
Gross Margin
76.6%
Profit Margin
-29.0%
Rev Growth
+40.0%
D/E Ratio
0.00
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 76.6% 76.6% 56.0% 56.0%
Operating Margin -35.8% -32.3% 19.2% 20.8%
Profit Margin -29.0% -27.5% 16.8% 12.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 137.97M 98.55M 45.49M 50.58M
Gross Profit 105.68M 75.49M 25.48M 28.33M
Operating Income -49,447,963 -31,787,976 8.73M 10.51M
Net Income -39,953,072 -25,684,117 7.66M 6.55M
Gross Margin 76.6% 76.6% 56.0% 56.0%
Operating Margin -35.8% -32.3% 19.2% 20.8%
Profit Margin -29.0% -27.5% 16.8% 12.9%
Rev Growth +40.0% +40.0% +1.5% +13.9%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 48.3K 48.3K 28.42M 28.12M
Total Equity 161.10M 161.10M 288.95M 248.82M
D/E Ratio 0.00 0.00 0.10 0.11
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -49,408,031 -33,526,878 11.61M 13.24M
Free Cash Flow 5.18M 4.95M